NASDAQ · Financial Statements
iTeos Therapeutics, Inc. (ITOS) Financial Statements
$10.15
NASDAQ: ITOS
Market Cap $448.68M
Overview Financials Dividend iTeos Therapeutics, Inc. most recently reported annual revenue of $35.0M, net profit of $-134.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $345.0M $268.0M $13.0M $35.0M Operating Profit $-45.0M $245.0M $126.0M $-151.0M $-160.0M Net Profit $-38.0M $215.0M $97.0M $-113.0M $-134.0M EPS $-1.24 $5.68 $2.56 $-3.15 $-3.32 Op Margin — 71.0% 47.2% -1199.7% -455.8%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $345.0M $885.0M $755.0M $668.0M $687.0M Total Liabilities $21.0M $332.0M $92.0M $92.0M $97.0M Cash $336.0M $849.0M $285.0M $251.0M $142.0M Borrowings $0 $5.0M $5.0M $6.0M $5.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-25.0M $513.0M $-111.0M $-104.0M $-98.0M Investing Cash Flow $-1.0M $-2.0M $-447.0M $70.0M $-133.0M Financing Cash Flow $2.0M $1.0M $1.0M $1.0M $2.0M Net Cash Flow $316.0M $512.0M $-564.0M $-34.0M $-109.0M Free Cash Flow $-26.0M $512.0M $-112.0M $-107.0M $-100.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.07 EV / EBITDA -2.46 FCF Yield -17.07% Quick Ratio 7.53 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock